Groowe Groowe BETA / Newsroom
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

Global Microcarriers Market Poised for Strong Growth Through 2034, Fueled by Rising Cell Therapy, Vaccine Production and Biomanufacturing Demand

globenewswire.com
TMO Thermo Fisher Scientific is mentioned as a leading company in the global microcarrier market, which is poised for strong growth. This suggests a positive outlook for the company's involvement in this expanding sector. AMZN Amazon is not explicitly mentioned in the article. Therefore, no sentiment can be extracted for this company. AMGN The article discusses the growing demand for biopharmaceuticals, biologics, vaccines, and advanced therapies, which are key products for companies like Amgen. This indicates a positive market environment for Amgen's offerings. BMY The article highlights the increasing demand for biologics, vaccines, and advanced therapies, which are central to Bristol Myers Squibb's business. This suggests a favorable market trend for the company. DHR Danaher Corporation is listed as a prominent company in the global microcarrier market, which is experiencing strong growth. This positions Danaher favorably within this expanding industry. REGN The article's focus on the growth of cell therapy, vaccine production, and biomanufacturing, along with the increasing demand for biologics and advanced therapies, creates a positive outlook for Regeneron Pharmaceuticals. BNTX The article emphasizes the strong growth in vaccine manufacturing and cell therapy, which are core areas for BioNTech. This indicates a positive market trend for the company's focus. MRK The article discusses the growing demand for biologics, vaccines, and advanced therapies, which are key areas for Merck & Co. This suggests a positive market environment for the company's products and research. COR Corning Inc. is identified as a key player in the global microcarrier market, which is projected for strong growth. This indicates a positive outlook for Corning's participation in this expanding sector. BDX Becton, Dickinson and Company is listed as a prominent company in the global microcarrier market, which is expected to grow significantly. This suggests a positive market position for the company. BIIB The article's emphasis on cell therapy, gene therapy, and regenerative medicine creates a positive market outlook for Biogen Inc., which is active in these areas. GILD The article highlights the increasing demand for biologics, vaccines, and advanced therapies, which are key areas for Gilead Sciences. This suggests a favorable market trend for the company. VRTX The article's focus on cell therapy, regenerative medicine, and advanced therapies creates a positive market outlook for Vertex Pharmaceuticals, which is involved in these fields. MDLZ Mondelez International is not mentioned in the article. No sentiment can be determined. BKR Baker Hughes Company is not mentioned in the article. No sentiment can be determined. BIO Bio-Rad Laboratories, Inc. is identified as a key player in the global microcarrier market, which is forecast for significant growth. This suggests a positive outlook for the company's involvement in this sector. GEHC The article's emphasis on cell therapy, vaccine production, and biomanufacturing, along with the growing demand for biologics and advanced therapies, creates a positive market outlook for GE HealthCare. MDT The article's focus on regenerative medicine, cell therapy, and advanced therapies creates a positive market outlook for Medtronic plc, which is active in these healthcare segments. ES Eastman Chemical Company is not mentioned in the article. No sentiment can be determined.

Global Microcarriers Market Poised for Strong Growth Through 2034, Fueled by Rising Cell Therapy, Vaccine Production and Biomanufacturing Demand Dublin, Sept. 17, 2026 (GLOBE NEWSWIRE) -- "Global Microcarriers Market Report by Product Type, Consumables, Application, End User, Countries and Company Analysis 2026-2034" has been added to ResearchAndMarkets.com's offering.

The global microcarrier market is forecast to grow from US$ 2.06 billion in 2025 to US$ 3.49 billion by 2034, registering a compound annual growth rate of 6.03% from 2026 to 2034. Market expansion is being supported by rising demand for large-scale cell culture, increased production of vaccines and biologics, and accelerating investment in regenerative medicine, cell therapy and gene therapy.

Microcarriers are widely used in biopharmaceutical manufacturing to support the high-density cultivation of anchorage-dependent cells in bioreactors. Their applications include vaccine manufacturing, monoclonal antibody production, recombinant proteins, viral vectors, stem cell expansion, tissue engineering and advanced cell-based therapies. As pharmaceutical and biotechnology companies seek higher yields, scalable processing and consistent product quality, microcarrier-based cell culture systems are becoming increasingly important.

Key Microcarrier Market Growth Drivers

Growing global demand for biopharmaceuticals is a primary market driver. The rising prevalence of chronic diseases, cancer and infectious diseases has increased demand for biologic medicines, vaccines and advanced therapies. Microcarrier technology enables manufacturers to expand adherent cells efficiently while supporting scalable production in controlled bioreactor environments.

Cell and gene therapy development is also creating substantial opportunities. Regenerative medicine, personalized medicine, stem cell therapy, cancer immunotherapy and tissue engineering require reliable methods for producing large quantities of viable therapeutic cells. The expanding number of clinical trials and regulatory approvals is encouraging biotechnology companies, research institutes and contract manufacturers to invest in microcarrier systems.

Advances in bioprocessing technology are further strengthening the global microcarrier market outlook. Improved surface materials, chemically defined media, animal component-free solutions, automated monitoring and single-use bioreactors are enhancing cell adhesion, proliferation and process control. Research into biodegradable and xeno-free microcarriers is also helping manufacturers address regulatory, safety and sustainability requirements.

Market Challenges

High production and operating costs remain a significant barrier, particularly for small and medium-sized biopharmaceutical companies. Microcarrier-based manufacturing can require specialized bioreactors, culture media, growth factors, monitoring systems and experienced personnel. These requirements may restrict adoption in markets with limited biotechnology infrastructure.

Process complexity presents an additional challenge. Successful cultivation requires precise control of agitation, oxygen transfer, pH, nutrient distribution and harvesting conditions. Scaling production from laboratory development to commercial manufacturing can also affect cell behavior and product consistency. Differences among cell lines make standardization difficult and increase the need for customized process optimization.

Product and Application Outlook

Consumables-including microcarrier beads, media, reagents, buffers and disposable materials-are expected to benefit from recurring demand across production batches. Adoption of ready-to-use, contamination-resistant and animal component-free consumables is increasing as manufacturers transition toward more efficient bioprocessing workflows.

The equipment segment includes bioreactors, mixing systems, filtration platforms, cell culture equipment and monitoring technologies. Demand is being driven by investment in modular manufacturing facilities, automation and single-use bioreactor systems. Cell therapy and vaccine manufacturing are among the most prominent applications, with microcarriers supporting commercial-scale cell expansion and high-density cultivation of virus-producing cells.

Recent Microcarrier Industry Developments

Regional Market Outlook

The United States remains a leading microcarrier market due to its established biopharmaceutical industry, extensive research funding, advanced manufacturing infrastructure and strong pipeline of biologics, vaccines and cell-based therapies. Continued innovation in single-use bioreactors and novel microcarrier materials is expected to support market growth.

The United Kingdom benefits from collaboration among universities, biotechnology companies, healthcare institutions and life sciences clusters. Investment in precision medicine, regenerative medicine and sustainable biomanufacturing is increasing demand for scalable cell culture technologies.

India is experiencing rapid growth because of its position as a major vaccine and biopharmaceutical manufacturing hub. Expanding biotechnology parks, contract manufacturing capacity, biosimilar production and government support are strengthening demand for microcarrier equipment and consumables.

Saudi Arabia is emerging as a promising market under Vision 2030. Investment in local vaccine production, pharmaceutical manufacturing, biomedical research and biotechnology partnerships is supporting adoption of advanced cell culture and microcarrier technologies.

Microcarrier Market Segmentation

Leading Companies in the Global Microcarrier Market

Prominent companies operating in the market include Thermo Fisher Scientific, Merck KGaA, Eppendorf AG, Danaher Corporation, Sartorius AG, Bio-Rad Laboratories, Corning Inc., Lonza Group, Getinge, and Becton, Dickinson and Company. Competitive analysis includes company overviews, key personnel, recent developments, SWOT assessments and revenue analysis.

With biologics, vaccines and advanced cell therapies occupying a growing share of pharmaceutical development pipelines, demand for scalable cell culture solutions is expected to remain strong. Continued innovation in microcarrier materials, bioreactor systems and automated bioprocessing platforms will be central to the global microcarrier market's expansion through 2034.

Key Attributes:

Key Topics Covered:

1. Introduction

2. Research & Methodology

2.1 Data Source

2.1.1 Primary Sources

2.1.2 Secondary Sources

2.2 Research Approach

2.2.1 Top-Down Approach

2.2.2 Bottom-Up Approach

2.3 Forecast Projection Methodology

3. Executive Summary

4. Market Dynamics

4.1 Growth Drivers

4.2 Challenges

5. Global Microcarriers Market

5.1 Historical Market

5.2 Market Forecast

6. Market Share Analysis

6.1 By Product Type

6.2 By Consumables

6.3 By Application

6.4 By End User

6.5 By Countries

7. Product Type

7.1 Consumables

7.1.1 Microcarrier Beads

7.1.1.1 Historical Market

7.1.1.2 Market Forecast

7.1.2 Media & Reagents

7.1.2.1 Historical Market

7.1.2.2 Market Forecast

7.2 Equipment

7.2.1 Historical Market

7.2.2 Market Forecast

8. Application

8.1 Cell Therapy

8.1.1 Historical Market

8.1.2 Market Forecast

8.2 Vaccine Manufacturing

8.2.1 Historical Market

8.2.2 Market Forecast

8.3 Others

8.3.1 Historical Market

8.3.2 Market Forecast

9. End User

9.1 Pharmaceutical & Biotechnology Companies

9.1.1 Historical Market

9.1.2 Market Forecast

9.2 Contract Research Organizations & Contract Manufacturing Organizations

9.2.1 Historical Market

9.2.2 Market Forecast

9.3 Academic & Research Institutes

9.3.1 Historical Market

9.3.2 Market Forecast

10. Countries

10.1 North America

10.1.1 United States

10.1.1.1 Historical Market

10.1.1.2 Market Forecast

10.1.2 Canada

10.1.2.1 Historical Market

10.1.2.2 Market Forecast

10.2 Europe

10.2.1 France

10.2.1.1 Historical Market

10.2.1.2 Market Forecast

10.2.2 Germany

10.2.2.1 Historical Market

10.2.2.2 Market Forecast

10.2.3 Italy

10.2.3.1 Historical Market

10.2.3.2 Market Forecast

10.2.4 Spain

10.2.4.1 Historical Market

10.2.4.2 Market Forecast

10.2.5 United Kingdom

10.2.5.1 Historical Market

10.2.5.2 Market Forecast

10.2.6 Belgium

10.2.6.1 Historical Market

10.2.6.2 Market Forecast

10.2.7 Netherlands

10.2.7.1 Historical Market

10.2.7.2 Market Forecast

10.2.8 Turkey

10.2.8.1 Historical Market

10.2.8.2 Market Forecast

10.3 Asia Pacific

10.3.1 China

10.3.1.1 Historical Market

10.3.1.2 Market Forecast

10.3.2 Japan

10.3.2.1 Historical Market

10.3.2.2 Market Forecast

10.3.3 India

10.3.3.1 Historical Market

10.3.3.2 Market Forecast

10.3.4 Australia

10.3.4.1 Historical Market

10.3.4.2 Market Forecast

10.3.5 South Korea

10.3.5.1 Historical Market

10.3.5.2 Market Forecast

10.3.6 Thailand

10.3.6.1 Historical Market

10.3.6.2 Market Forecast

10.3.7 Malaysia

10.3.7.1 Historical Market

10.3.7.2 Market Forecast

10.3.8 Indonesia

10.3.8.1 Historical Market

10.3.8.2 Market Forecast

10.3.9 New Zealand

10.3.9.1 Historical Market

10.3.9.2 Market Forecast

10.4 Latin America

10.4.1 Brazil

10.4.1.1 Historical Market

10.4.1.2 Market Forecast

10.4.2 Mexico

10.4.2.1 Historical Market

10.4.2.2 Market Forecast

10.4.3 Argentina

10.4.3.1 Historical Market

10.4.3.2 Market Forecast

10.5 Middle East & Africa

10.5.1 South Africa

10.5.1.1 Historical Market

10.5.1.2 Market Forecast

10.5.2 Saudi Arabia

10.5.2.1 Historical Market

10.5.2.2 Market Forecast

10.5.3 UAE

10.5.3.1 Historical Market

10.5.3.2 Market Forecast

11. Porter's Five Forces Analysis

11.1 Bargaining Power of Buyers

11.2 Bargaining Power of Suppliers

11.3 Degree of Competition

11.4 Threat of New Entrants

11.5 Threat of Substitutes

12. SWOT Analysis

12.1 Strength

12.2 Weakness

12.3 Opportunity

12.4 Threats

13. Key Players Analysis

13.1 Thermo Fisher Scientific

13.1.1 Overviews

13.1.2 Key Person

13.1.3 Recent Developments

13.1.4 SWOT Analysis

13.1.5 Revenue Analysis

13.2 Merck KGaA

13.2.1 Overviews

13.2.2 Key Person

13.2.3 Recent Developments

13.2.4 SWOT Analysis

13.2.5 Revenue Analysis

13.3 Eppendorf AG

13.3.1 Overviews

13.3.2 Key Person

13.3.3 Recent Developments

13.3.4 SWOT Analysis

13.3.5 Revenue Analysis

13.4 Danaher Corporation

13.4.1 Overviews

13.4.2 Key Person

13.4.3 Recent Developments

13.4.4 SWOT Analysis

13.4.5 Revenue Analysis

13.5 Sartorius AG

13.5.1 Overviews

13.5.2 Key Person

13.5.3 Recent Developments

13.5.4 SWOT Analysis

13.5.5 Revenue Analysis

13.6 Bio-Rad Laboratories, Inc.

13.6.1 Overviews

13.6.2 Key Person

13.6.3 Recent Developments

13.6.4 SWOT Analysis

13.6.5 Revenue Analysis

13.7 Corning Inc.

13.7.1 Overviews

13.7.2 Key Person

13.7.3 Recent Developments

13.7.4 SWOT Analysis

13.7.5 Revenue Analysis

13.8 Lonza Group

13.8.1 Overviews

13.8.2 Key Person

13.8.3 Recent Developments

13.8.4 SWOT Analysis

13.8.5 Revenue Analysis

13.9 Getinge

13.9.1 Overviews

13.9.2 Key Person

13.9.3 Recent Developments

13.9.4 SWOT Analysis

13.9.5 Revenue Analysis

13.10 Becton, Dickinson and Company

13.10.1 Overviews

13.10.2 Key Person

13.10.3 Recent Developments

13.10.4 SWOT Analysis

13.10.5 Revenue Analysis

Companies Featured

For more information about this report visit https://www.researchandmarkets.com/r/np3nsg

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.